391 related articles for article (PubMed ID: 17461867)
1. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
[TBL] [Abstract][Full Text] [Related]
2. "Tuned" defibrillation waveforms outperform 50/50% tilt defibrillation waveforms: a randomized multi-center study.
Natarajan S; Henthorn R; Burroughs J; Esberg D; Zweibel S; Ross T; Kroll M; Gianola D; Oza A
Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S139-42. PubMed ID: 17302691
[TBL] [Abstract][Full Text] [Related]
3. Effect of an active abdominal pulse generator on defibrillation thresholds with a dual-coil, transvenous ICD lead system.
Rashba EJ; Farasat M; Kirk MM; Shorofsky SR; Peters RW; Gold MR
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):617-20. PubMed ID: 16836709
[TBL] [Abstract][Full Text] [Related]
4. Quadriphasic waveforms are superior to triphasic waveforms for transthoracic defibrillation in a cardiac arrest swine model with high impedance.
Zhang Y; Rhee B; Davies LR; Zimmerman MB; Snyder D; Jones JL; Kerber RE
Resuscitation; 2006 Feb; 68(2):251-8. PubMed ID: 16325983
[TBL] [Abstract][Full Text] [Related]
5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
6. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
[TBL] [Abstract][Full Text] [Related]
7. Effect of rapid biphasic shock subpulse switching on ventricular defibrillation thresholds.
Dosdall DJ; Rothe DE; Brandon TA; Sweeney JD
J Cardiovasc Electrophysiol; 2004 Jul; 15(7):802-8. PubMed ID: 15250866
[TBL] [Abstract][Full Text] [Related]
8. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
[TBL] [Abstract][Full Text] [Related]
9. Surgical open-chest ventricular defibrillation: triphasic waveforms are superior to biphasic waveforms.
Zhang Y; Boddicker KA; Davies LR; Jones JL; Kerber RE
Pacing Clin Electrophysiol; 2004 Jul; 27(7):941-8. PubMed ID: 15271014
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fixed tilt and tuned defibrillation waveforms: the PROMISE study.
Gold MR; Val-Mejias J; Cuoco F; Siddiqui M
J Cardiovasc Electrophysiol; 2013 Mar; 24(3):323-7. PubMed ID: 23210764
[TBL] [Abstract][Full Text] [Related]
11. Multicenter study of principles-based waveforms for external defibrillation.
Bain AC; Swerdlow CD; Love CJ; Ellenbogen KA; Deering TF; Brewer JE; Augostini RS; Tchou PJ
Ann Emerg Med; 2001 Jan; 37(1):5-12. PubMed ID: 11145764
[TBL] [Abstract][Full Text] [Related]
12. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
[TBL] [Abstract][Full Text] [Related]
13. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
14. Optimization of atrial defibrillation with a dual-coil, active pectoral lead system.
Rashba EJ; Shorofsky SR; Peters RW; Gold MR
J Cardiovasc Electrophysiol; 2004 Jul; 15(7):790-4. PubMed ID: 15250864
[TBL] [Abstract][Full Text] [Related]
15. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
[TBL] [Abstract][Full Text] [Related]
16. BIPHASIC Trial: a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest.
Stiell IG; Walker RG; Nesbitt LP; Chapman FW; Cousineau D; Christenson J; Bradford P; Sookram S; Berringer R; Lank P; Wells GA
Circulation; 2007 Mar; 115(12):1511-7. PubMed ID: 17353443
[TBL] [Abstract][Full Text] [Related]
17. [The effect of the impulse form of the defibrillation shock on its effectiveness and device technology of the implantable cardiac defibrillator].
Jung W; Manz M; Lüderitz B
Herz; 1994 Oct; 19(5):251-8. PubMed ID: 8001898
[TBL] [Abstract][Full Text] [Related]
18. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
[TBL] [Abstract][Full Text] [Related]
19. Benefit of millisecond waveform durations for patients with high defibrillation thresholds.
Denman RA; Umesan C; Martin PT; Forbes RN; Kroll MW; Anskey EJ; Burnett HE
Heart Rhythm; 2006 May; 3(5):536-41. PubMed ID: 16648057
[TBL] [Abstract][Full Text] [Related]
20. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
